Protein C Inhibitor-A Novel Antimicrobial Agent

Open Access
Authors
  • E. Malmström
  • M. Mörgelin
  • M. Malmsten
  • L. Johansson
  • A. Norrby-Teglund
  • O. Shannon
  • A. Schmidtchen
  • J.C.M. Meijers
  • H. Herwald
Publication date 2009
Journal PLoS Pathogens
Volume | Issue number 5 | 12
Pages (from-to) e1000698
Organisations
  • Faculty of Medicine (AMC-UvA)
Abstract
Protein C inhibitor (PCI) is a heparin-binding serine proteinase inhibitor belonging to the family of serpin proteins. Here we describe that PCI exerts broad antimicrobial activity against bacterial pathogens. This ability is mediated by the interaction of PCI with lipid membranes, which subsequently leads to their permeabilization. As shown by negative staining electron microscopy, treatment of Escherichia coli or Streptococcus pyogenes bacteria with PCI triggers membrane disruption followed by the efflux of bacterial cytosolic contents and bacterial killing. The antimicrobial activity of PCI is located to the heparin-binding site of the protein and a peptide spanning this region was found to mimic the antimicrobial activity of PCI, without causing lysis or membrane destruction of eukaryotic cells. Finally, we show that platelets can assemble PCI on their surface upon activation. As platelets are recruited to the site of a bacterial infection, these results may explain our finding that PCI levels are increased in tissue biopsies from patients suffering from necrotizing fasciitis caused by S. pyogenes. Taken together, our data describe a new function for PCI in innate immunity
Document type Article
Published at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788422/pdf/ppat.1000698.pdf
Downloads
321346.pdf (Final published version)
Permalink to this page
Back